Myomectomy Market
Myomectomy Market Forecasts to 2030 - Global Analysis By Product (Laparoscopic Power Morcellators, Laparoscopic Sealer, Harmonic Scalpel and Other Products), Type (Abdominal Myomectomy, Laparoscopic Myomectomy, Hysteroscopic Myomectomy and Robotic Myomectomy ), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $756.59 MN |
|
Projected Year Value (2030) |
US $1,580.73 MN |
|
CAGR (2023 - 2030) |
11.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Myomectomy Market is accounted for $756.59 million in 2023 and is expected to reach $1,580.73 million by 2030 growing at a CAGR of 11.1% during the forecast period. A myomectomy is a surgical procedure aimed at removing noncancerous growths known as uterine fibroids from the muscular wall of the uterus. It is a viable alternative for women who want to avoid a hysterectomy or maintain their fertility. Furthermore, a number of techniques, such as open surgery, laparoscopy, and robotic-assisted surgery, can be used to carry out this procedure.
According to the Society for Women’s Health Research report, in the U.S. approximately 26 million women ages 15-50 have uterine fibroids.
Market Dynamics:
Driver:
Growing prevalence of uterine fibroids
Uterine fibroids are common benign tumours affecting a substantial number of women, particularly during their reproductive years. For instance, according to the Illinois Department of Public Health, around 77% of women of childbearing age may have uterine fibroids. Therefore, as more women have uterine fibroids diagnoses, there is a growing need for efficient treatment solutions to manage the resulting symptoms. Furthermore, minimally invasive techniques such as laparoscopy and robotic-assisted surgery are gaining popularity in myomectomy. This growing prevalence of uterine fibroids fuels the demand for myomectomy procedures, propelling the market's expansion
Restraint:
Fertility concerns
Myomectomy has the potential to affect fertility ability, even if the aim is to protect fertility by removing uterine fibroids. The surgical procedure, especially if multiple or large fibroids are removed, might lead to scarring or alterations in the uterus, potentially affecting reproductive capabilities. Women who wish to have children in the future are influenced by their concern about possible issues with their fertility after a myomectomy. This affects their decision-making process regarding treatment and may even restrict the market's expansion.
Opportunity:
Rising demand for minimally invasive procedures
Patients increasingly favour minimally invasive techniques like laparoscopic or robotic-assisted myomectomy due to reduced recovery times, less scarring, and a quicker return to daily activities. This growing preference aligns with the desire for effective yet less invasive treatments, especially among women seeking fertility preservation. Furthermore, healthcare providers offering these advanced procedures can attract more patients seeking myomectomy, addressing the rising demand for minimally invasive options and potentially expanding the market.
Threat:
Non-surgical alternatives
Advanced non-surgical treatments like uterine artery embolisation (UAE) or focused ultrasound surgery (FUS) offer effective options for treating uterine fibroids without surgery. The availability and increasing success rates of these non-surgical treatments pose a challenge to the traditional myomectomy market, potentially reducing the demand for surgical procedures and impacting the market's growth by offering compelling alternatives for fibroid management without surgical interventions.
Covid-19 Impact
The COVID-19 epidemic severely impacted women's healthcare and the market for myomectomy procedures. It caused delays in diagnosis and treatment, as well as the postponement of non-urgent treatments in the medical field. Also, interruptions in the supply chain impacted the accessibility of medical supplies required for myomectomy operations. In addition, hospitals diverted funds for COVID-19 therapy, which affected the focus on non-urgent medical operations. Consequently, COVID-19 limited the growth of the myomectomy market.
The laparoscopic myomectomy segment is expected to be the largest during the forecast period
The laparoscopic myomectomy segment is estimated to hold the largest share. Laparoscopic myomectomy involves a minimally invasive surgical procedure to remove uterine fibroids. This technique utilizes small incisions through which specialized instruments and a laparoscope are inserted, providing a magnified view of the uterus. Moreover, it offers benefits like shorter hospital stays, faster recuperation, and reduced postoperative complications. With increasing patient preference for minimally invasive options and advancements in laparoscopic techniques, this segment continues to gain traction as a preferred method for treating uterine fibroids.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period
The hospitals & clinics segment is anticipated to have lucrative growth during the forecast period. Hospitals and clinics equipped with advanced medical infrastructure and skilled healthcare professionals cater to patients seeking various treatment options for uterine fibroids. They offer comprehensive diagnostic evaluations, surgical expertise, and postoperative care, addressing patient needs with diverse surgical approaches such as laparoscopic, robotic-assisted, or open myomectomy procedures. In addition, hospitals and clinics play a pivotal role in delivering specialised care, contributing significantly to the accessible and comprehensive management of uterine fibroids through myomectomy.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to the increasing number of women suffering from uterine disorders and the rising investment in the surgical device industry by key players in developing economies. China and Japan have played a significant role in the market expansion for myomectomy procedures. The supply of highly skilled medical personnel, including surgeons and gynaecologists, as well as the rising need for technologically sophisticated medical technologies, such as gene chips, for research purposes, are the main reasons for this growth.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period, due to the rising prevalence of uterine fibroid and technological advancements in myomectomy procedures. According to the data updated by the United States Office on Women's Health in February 2021, it was estimated that about 20 percent to 80 percent of women developed fibroids by the time they reached age 50. Women in their 40s and early 50s are most likely to develop uterine fibroids. While not all fibroids cause symptoms, those who do frequently find living with their fibroids to be difficult. Thus, the high burden of uterine fibroids in the United States is expected to boost market growth.
Key players in the market
Some of the key players in the Myomectomy Market include Medtronic, Conmed Corporation, Stryker Corporation, Insightec, Hologic, Inc, Cooper Surgical Inc, Intuitive Surgical, Braun Melsungen AG, Minerva Surgical Inc, Johnson And Johnson Services Inc., Karl Storz, Boston Scientific Corporation, General Electric Company, F. Hoffmann-La Roche Ltd, Richard Wolf Medical Instruments, Siemens, Bayer, AbbVie Inc. and Halt Medical, Inc.
Key Developments:
In November 2022, Olympus announced the market launch of the moresolution Power Morcellator, manufactured by TROKAMED GmbH and available in the United States through a distribution agreement with Olympus America, Inc. The moresolution Morcellator is designed for advanced gynecologic procedures with large, calcified tissue specimens. Olympus's pneumoLiner and the moresolution Morcellator can provide select patients with a laparoscopic surgical option.
In April 2022, Ethicon, part of Johnson & Johnson MedTech, launched the ENSEAL X1 Straight Jaw Tissue Sealer. The ENSEAL X1 Straight Jaw is indicated for use in open and laparoscopic general, gynecological, and urologic procedures.
Products Covered:
• Laparoscopic Power Morcellators
• Laparoscopic Sealer
• Harmonic Scalpel
• Other Products
Types Covered:
• Abdominal Myomectomy
• Laparoscopic Myomectomy
• Hysteroscopic Myomectomy
• Robotic Myomectomy
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals & Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Myomectomy Market, By Product
5.1 Introduction
5.2 Laparoscopic Power Morcellators
5.3 Laparoscopic Sealer
5.4 Harmonic Scalpel
5.5 Other Products
6 Global Myomectomy Market, By Type
6.1 Introduction
6.2 Abdominal Myomectomy
6.3 Laparoscopic Myomectomy
6.4 Hysteroscopic Myomectomy
6.5 Robotic Myomectomy
7 Global Myomectomy Market, By End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Hospitals & Clinics
7.4 Other End Users
8 Global Myomectomy Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Medtronic
10.2 Conmed Corporation
10.3 Stryker Corporation
10.4 Insightec
10.5 Hologic, Inc
10.6 Cooper Surgical Inc
10.7 Intuitive Surgical
10.8 Braun Melsungen AG
10.9 Minerva Surgical Inc
10.10 Johnson And Johnson Services Inc.
10.11 Karl Storz
10.12 Boston Scientific Corporation
10.13 General Electric Company
10.14 F. Hoffmann-La Roche Ltd
10.15 Richard Wolf Medical Instruments
10.16 Siemens
10.17 Bayer
10.18 AbbVie Inc.
10.19 Halt Medical, Inc.
List of Tables
1 Global Myomectomy Market Outlook, By Region (2021-2030) ($MN)
2 Global Myomectomy Market Outlook, By Product (2021-2030) ($MN)
3 Global Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
4 Global Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
5 Global Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
6 Global Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
7 Global Myomectomy Market Outlook, By Type (2021-2030) ($MN)
8 Global Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
9 Global Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
10 Global Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
11 Global Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
12 Global Myomectomy Market Outlook, By End User (2021-2030) ($MN)
13 Global Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
14 Global Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
15 Global Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
16 North America Myomectomy Market Outlook, By Country (2021-2030) ($MN)
17 North America Myomectomy Market Outlook, By Product (2021-2030) ($MN)
18 North America Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
19 North America Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
20 North America Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
21 North America Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
22 North America Myomectomy Market Outlook, By Type (2021-2030) ($MN)
23 North America Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
24 North America Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
25 North America Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
26 North America Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
27 North America Myomectomy Market Outlook, By End User (2021-2030) ($MN)
28 North America Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
29 North America Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
30 North America Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
31 Europe Myomectomy Market Outlook, By Country (2021-2030) ($MN)
32 Europe Myomectomy Market Outlook, By Product (2021-2030) ($MN)
33 Europe Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
34 Europe Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
35 Europe Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
36 Europe Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
37 Europe Myomectomy Market Outlook, By Type (2021-2030) ($MN)
38 Europe Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
39 Europe Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
40 Europe Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
41 Europe Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
42 Europe Myomectomy Market Outlook, By End User (2021-2030) ($MN)
43 Europe Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
44 Europe Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
45 Europe Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
46 Asia Pacific Myomectomy Market Outlook, By Country (2021-2030) ($MN)
47 Asia Pacific Myomectomy Market Outlook, By Product (2021-2030) ($MN)
48 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
49 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
50 Asia Pacific Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
51 Asia Pacific Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
52 Asia Pacific Myomectomy Market Outlook, By Type (2021-2030) ($MN)
53 Asia Pacific Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
54 Asia Pacific Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
55 Asia Pacific Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
56 Asia Pacific Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
57 Asia Pacific Myomectomy Market Outlook, By End User (2021-2030) ($MN)
58 Asia Pacific Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
59 Asia Pacific Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
60 Asia Pacific Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
61 South America Myomectomy Market Outlook, By Country (2021-2030) ($MN)
62 South America Myomectomy Market Outlook, By Product (2021-2030) ($MN)
63 South America Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
64 South America Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
65 South America Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
66 South America Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
67 South America Myomectomy Market Outlook, By Type (2021-2030) ($MN)
68 South America Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
69 South America Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
70 South America Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
71 South America Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
72 South America Myomectomy Market Outlook, By End User (2021-2030) ($MN)
73 South America Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
74 South America Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
75 South America Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
76 Middle East & Africa Myomectomy Market Outlook, By Country (2021-2030) ($MN)
77 Middle East & Africa Myomectomy Market Outlook, By Product (2021-2030) ($MN)
78 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Power Morcellators (2021-2030) ($MN)
79 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Sealer (2021-2030) ($MN)
80 Middle East & Africa Myomectomy Market Outlook, By Harmonic Scalpel (2021-2030) ($MN)
81 Middle East & Africa Myomectomy Market Outlook, By Other Products (2021-2030) ($MN)
82 Middle East & Africa Myomectomy Market Outlook, By Type (2021-2030) ($MN)
83 Middle East & Africa Myomectomy Market Outlook, By Abdominal Myomectomy (2021-2030) ($MN)
84 Middle East & Africa Myomectomy Market Outlook, By Laparoscopic Myomectomy (2021-2030) ($MN)
85 Middle East & Africa Myomectomy Market Outlook, By Hysteroscopic Myomectomy (2021-2030) ($MN)
86 Middle East & Africa Myomectomy Market Outlook, By Robotic Myomectomy (2021-2030) ($MN)
87 Middle East & Africa Myomectomy Market Outlook, By End User (2021-2030) ($MN)
88 Middle East & Africa Myomectomy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
89 Middle East & Africa Myomectomy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
90 Middle East & Africa Myomectomy Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
